Evidence- and Value-based Solutions for Health Care™
Clinical Improvement Consults, Content Development, Training & Seminars, Tools
Recommended Reading |
The EBM Information Quest: Is it true? Is it useful? Is it usable?™
Delfini Co-founders: Michael E Stuart MD, President & Medical Director . Sheri Ann Strite, Managing Director & Principal |
Quick Picks
Why Critical Appraisal Matters
Services
Seminars
Books
Updates & Contact Info
Free Online Tools
Free Online Tutorial
Delfini Blog
Follow & Share...
Just-in-time Updates
Like Us Find Us |
Delfini
Text BookDelfini Evidence-based Practice Short How-to Guide Book now available for purchase.
|
DelfiniGram™: GET ON OUR UPDATE LIST
This
is generally a list of readings from sources other than Delfini. We include
our work where especially relevant; but otherwise look for other relevant
readings from our work using the Quick Navigator.
Contents
|
At Recommended Reading
Read Our Blog...
Menu........
Use of our website implies agreement to our Notices. Citations for references available upon request.
Home
Best of Delfini
What's New
Blog
Seminars
Services
Delfini Group Publishing
Resources
Sample Projects
Notices
About
Us & Our Work
Testimonials
Other
Site Search
Contact
Info/Updates
........
Quick
Navigator to Selected Resources
.......................
|
Clinical
Quality Improvement |
Strite
S, Stuart M
The EBM Organization: Three-part series by Delfini published in The Physician Executive, Journal of Medical Management
http://www.delfini.org/Showcase_Publication_PhysicianExecutive.htm
Rosser WW, Davis D, Gilbart
E.
Assessing Guidelines for Use in Family Practice.
Journal of Family Practice 2001; 50: 969-973.
http://www.jfponline.com/Pages.asp?AID=2392&UID=
Hayward RSA et al.
User’s Guides to the Medical Literature, VIII: How
to Use Clinical Practice Guidelines, A: Are the recommendations valid?
JAMA. 1995; 274: 570-574.
http://www.jamaevidence.com/resource/520
Wilson MC et al.
User’s Guides to the Medical Literature, VIII: How
to Use Clinical Practice Guidelines, B: What are the recommendations and
will they help you in caring for your patients?
JAMA. 1995; 274: 1630-1632.
Bero LA et al. for the Cochrane
Effective Practice and Organization of Care Review Group.
Closing the gap between research and practice: an overview of
systematic reviews of interventions to promote the implementation of research
findings.
BMJ.1998;317:465-468
http://bmj.com/cgi/content/full/317/7156/465
NHS Centre for Review and
Dissemination.
Effective Health Care. Getting Evidence into Practice.
London, England: Royal Society of Medicine Press;1999. http://www.york.ac.uk/inst/crd/EHC/ehc51.pdf
Oxman AD et al.
No magic bullets: a systematic review of 102 trials of interventions
to improve professional practice.
CMAJ 1995;153:1423-1431.
http://www.jamaevidence.com/resource/520
Also see Delfini Health
Care System Tool Set. |
Formulary
Management |
Strite
SA, Stuart ME, Urban S.
Process steps and suggestions for creating drug monographs and
drug class reviews in an evidence-based formulary system.
Formulary. April 2008;43:135–145.
http://www.delfini.org/Showcase_Publication_Formulary.htm
Strite SA, Stuart ME.
An Introduction to Systematic Reviews: The Lifeblood of Medical
Decision-making.
California Pharmacist 2008. Vol LV, No. 3. Summer 2008: 52-56.
http://www.delfini.org/Showcase_Publication_CPhA.htm
Chiquette E, Posey LM.
Evidence-based Pharmacotherapy.
American Pharmacists Association. APhA Publications; 1 edition (January
15, 2007).
Contributing Authors Include —
Strite SA, Stuart ME, contributing authors. Chapter 7. Applying Evidence-Based
Pharmacotherapy to Formulary Decisions
http://www.delfini.org/Showcase_Publication_EBPharmacotherapy.htm
Here is survey work that describes needs and perceptions:
Ryan Rodriguez, PharmD, BCPS; Brett J. Kelly, BSPharm, MS; and Mary Moody, BSPharm
Evaluating the Training, Responsibilities, and Practices of
P&T Committee Members and Nonmember Contributors
Here is a paper that presents a perspective from a group we worked with:
Raulo S. Frear, PharmD
Experimental and Observational Data and Formulary Listing |
Balance
Sheets |
Braddick
M, Stuart M, Hrachovec J.
The use of balance sheets in developing clinical guidelines.
J Am Board Fam Pract. 1999 Jan-Feb;12(1):48-54. Erratum in: J Am Board Fam
Pract 1999 Mar-Apr;12(2):187. PMID: 10050643
Made available to our readers through the kind permission of the Journal of the American Board of Family Medicine. Their webside is here: www.jabfm.org. See above link to read the article. |
Implementation |
Glasziou P, Haynes B. The paths from research to improved health outcomes. Evid Based Nurs. 2005 Apr;8(2):36-8. PubMed PMID: 15830412.
Grimshaw J, Eccles M, Thomas R, MacLennan G, Ramsay C, Fraser C, Vale L. Toward evidence-based quality improvement. Evidence (and its limitations) of he effectiveness of guideline dissemination and implementation strategies 1966-1998. J Gen Intern Med. 2006 Feb;21 Suppl 2:S14-20.
Grol R et al.
Evidence-based Implementation of Evidence-based Medicine.
Journal of Quality Improvement. 1999; 25: 10; 503-513.
PubMed Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/10522231?dopt=Abstract
Grol R et al.
Attributes of clinical guidelines that influence use of guidelines
in general practice: observational study.
BMJ 1998; 317:858-861.
Full Text:
http://bmj.bmjjournals.com/cgi/content/abstract/317/7162/858
Lomas
J, Haynes RB.
A taxonomy and critical review of tested strategies for the application
of clinical practice recommendations from “official” to “individual”
clinical policy.
AM J Prevent Med. 1988;4:77-94
PubMed Reference:
http://www.ncbi.nlm.nih.gov/pubmed/3079143?dopt=Abstract
Rogers EM.
Diffusion of Innovations. 3rd Edition. The Free Press.
New York; 1983.Scott IA, Glasziou PP. Improving effectiveness of clinical medicine: the need for better translation of science into practice. Med J Aust. 2012 Oct 1;197(7):374-8. PubMed PMID: 23025728.
Solberg
L et al.
Lessons from Experienced Guideline Implementers: Attend to Many
Factors and Use Multiple Strategies.
Journal of Quality Improvement. 2000; 26: 171-188.
PubMed Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/10749003?dopt=Abstract
Wensing, M et al.
Implementing guidelines and innovations in general practice: which
interventions are effective?
British Journal of General Practice. Feb 1998; 48:991-997.
PubMed Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/9624774?dopt=Abstract
Yank V, Tribett E, Green L, Pettis J, Learning from Marketing: Rapid Development of Medication Messages that Engage Patients, Patient Education and Counseling (2015), http://dx.doi.org/10.1016/j.pec.2015.02.016
|
Performance
Measurement |
Stuart
M, Strite S
Pitfalls to Performance Measurement: Article by Delfini published in Modern Healthcare
http://www.delfini.org/Showcase_Publication_PerformanceMeasures.htm
National Quality
Measures Clearinghouse (NQMC): Includes many educational documents
and an archive of quality and performance measures
http://www.qualitymeasures.ahrq.gov/
Bagley B.
How does your practice measure up?
Fam Pract Manag. 2006 Jul-Aug;13(7):59-64.
PMID: 16909830
http://www.aafp.org/fpm/20060700/59howd.html
Nerenz DR, Neil N
Performance Measures for Health Care Systems
To access, copy the following into an internet search engine:
www.hret.org/hret/programs/chmr/content/cp19a.pdf
Vijan, Sandeep
Are We Overvaluing Performance Measures?
Effective Clinical Practice ACP site: http://ecp.acponline.org/sepoct00/overvalue.htm
Landon BE, Normand ST, Blumenthal
D, Daley J.
Physician clinical performance assessment: prospects and barriers.
JAMA. 2003;290:1183-1189.
Walter LC, Davidowitz NP,
Heineken PA et al.
Pitfalls of Converting Practice Guidelines into Quality Measures:
Lessons Learned from a VA Performance Measure.
JAMA. 2004;2901:2466-2470. Abstract.
Hofer TP, Hayward RA, Greenfield
S, Wagner EH, Kaplan SH, Manning WG.
The unreliability of individual physician "report cards"
for assessing the costs and quality of care of a chronic disease.
JAMA. 1999 Jun 9;281(22):2098-105.
PMID: 10367820 Abstract. |
Evidence-based
Medicine |
Here
is a nice, short general write up on what evidence-based medicine is. NOTE: We do have a couple
of issues. 1. We would amend to say "best available valid and clinically
useful evidence." 2. And we are often asked about industry research.
We say that everyone has a potential bias — critically appraise
every study, every secondary source, for validity and clinical usefulness.
And yet, we also think overall this is a nice intro to EBM.
Dickersin K, Straus SE, Bero
LA.
Evidence based medicine: increasing, not dictating, choice.
BMJ. 2007 Jan 6;334 Suppl 1:s10. PMID: 17204750.
Cochrane
Handbook
The Cochrane Handbook for Systematic Reviews of Interventions
is a useful resource for all
healthcare professionals doing critical appraisal of the medical literature.
It was created to assist authors preparing systematic reviews (SRs) but
is of great value to all of us who are assessing validity of studies.
The section of interest is Part 2: General methods for Cochrane reviews.
http://www.cochrane-handbook.org/ |
General
Books on Evidence-based Medicine Topics & Clinical Epidemiology |
Eddy,
David
Clinical Decision Making: From Theory to Practice: A Collection
of Essays From the Journal of the American Medical Association
Jones & Bartlett Pub; 1st edition (January 15, 1996)
Fletcher, Robert H, Suzanne
W. Fletcher and Edward H. Wagner
Clinical Epidemiology: The Essentials.
Philadelphia PA. Lippincott Williams & Wilkins, 1996.
Geyman, John P., Richard
A. Deyo, Scott D. Ramsey
Evidence-based Clinical Practice — Concepts and Approaches
Butterworth Heinemann, 2000.
Guyatt, Gordon and Rennie
Drummond, ed. The Evidence-Based Medicine Working Group
Users' Guides to the Medical Literature: Essentials of Evidence-Based
Clinical Practice.
AMA Press, 2002.
Jekel, James F., Joann G.
Elmore, David L. Katz
Epidemiology, Biostatistics and Preventive Medicine
WB Saunders Company, 1996
Riegelman, Richard
Studying a Study and Testing a Test.
Philadelphia PA. Lippincott Williams & Wilkins, 2000.
Straus SE, Richardson
WS, Glasziou P, Haynes RB. Evidence-based Medicine: How to Practice
and Teach EBM. 3rd Ed. Elsevier Churchill Livingston, 2005.
Click here to go to Delfini critical appraisal tools in our Evidence Tool Set. Click here for Delfini Primers. |
Critical
Appraisal — General |
Delfini Primers
& Evidence Tools
The
Consort Statement: Consolidated Standards of Reporting Trials —CONSORT
"The CONSORT statement is an important
research tool that takes an evidence-based approach to improve the quality
of reports of randomized trials. The statement is available in six languages
and has been endorsed by prominent medical journals such as The Lancet,
Annals of Internal Medicine, and the Journal of the American Medical Association.
Its critical value to researchers, health care providers, peer reviewers,
and journal editors, and health policy makers is the guarantee of integrity
in the reported results of research.
CONSORT comprises a checklist and flow diagram to help improve the quality
of reports of randomized controlled trials. It offers a standard way for
researchers to report trials. The checklist includes items, based on evidence,
that need to be addressed in the report; the flow diagram provides readers
with a clear picture of the progress of all participants in the trial,
from the time they are randomized until the end of their involvement.
The intent is to make the experimental process more clear, flawed or not,
so that users of the data can more appropriately evaluate its validity
for their purposes."
http://www.consort-statement.org/
Gluud LL.
Bias in Clinical Intervention Research.
Am J Epidemiol 2006;163:493–501
PMID: 17119141
Ioannidis JPA (2005)
Why most published research findings are false.
PLoS Med 2(8): e124
PMID: 16060722
Direct access here.
Juni P, Altman DG, Egger
M.
Systematic reviews in health care: Assessing the quality of controlled
clinical trials.
BMJ. 2001 Jul 7;323(7303):42-6.
PMID: 11440947 |
Randomization |
Schulz
KF, Grimes DA.
Generation of allocation sequences in randomised trials: chance,
not choice.
Lancet 2002; 359: 515–19.
PMID: 11853818 |
Concealment
of Allocation |
Viera
AJ, Bangdiwala SI.
Eliminating bias in randomized controlled trials: importance of
allocation concealment and masking.
Fam Med. 2007 Feb;39(2):132-8.
PMID: 17273956
Direct access here. |
Blinding |
Boutron
I, Estellat C, Guittet L, Dechartres A, Sackett DL, et al. (2006)
Methods of blinding in reports of randomized controlled trials
assessing pharmacologic treatments: A systematic review. PLoS Med 3(10): e425. DOI: 10.1371/ journal.
PMID: 17076559
Direct access here.
Flum DR. Interpreting Surgical Trials With Subjective Outcomes Avoiding
UnSPORTsmanlike Conduct. JAMA, November 22/29, 2006—Vol 296, No. 20: 2483-1484.
PMID: 17119146
See Delfini commentary in related DelfiniClick™
Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ. 2001 Jul 7;323(7303):42-6. Review. PubMed PMID: 11440947; PubMed Central PMCID: PMC1120670.
Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 2001 Dec 4;135(11):982-9. Erratum in: Ann Intern Med. 2008 Aug 5;149(3):219. PubMed PMID: 11730399.
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998 Aug 22;352(9128):609-13. PubMed PMID: 9746022.
Schulz KF, Chalmers I, Hayes
RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality
associated with estimates of of treatment effects in controlled trials. JAMA 1995;273:40812.
PMID: 7823387
See Delfini commentary in related DelfiniClick™
Viera AJ, Bangdiwala SI. Eliminating bias in randomized controlled trials: importance of
allocation concealment and masking.Fam Med. 2007 Feb;39(2):132-8.
PMID: 17273956
Direct access here.
Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008 Mar 15;336(7644):601-5. Epub 2008 Mar 3. PubMed PMID: 18316340; PubMed Central PMCID:PMC2267990.
See Delfini commentary in related DelfiniClick™ on blinding and objective outcomes.
And on Testing for Success of Blinding:
Sackett DL. Turning a blind eye: why we don't test for blindness at the end of our trials. BMJ. 2004 May 8;328(7448):1136. PubMed PMID: 15130997; PubMed Central PMCID: PMC406365.
See Delfini commentary in related DelfiniClick™. |
Analysis
(see Intention-to-Treat Analysis also) |
Kaplan
Meier curves explained: http://cancerguide.org/scurve_km.html
See also Delfini
Tools & Educational Library for 1-pager. |
Intention-to-Treat
Analysis |
Schulz
KF, Grimes DA
Sample size slippages in randomised trials: exclusions and the
lost and wayward.
The Lancet. Vol 359. March 2, 2002: 781-785
PMID: 11888606
NOTE: Delfini stresses that
the approach taken for missing values should not give an advantage to
the intervention.
Hollis S, Campbell F
What is meant by intention to treat analysis? Survey of published
randomised controlled trials.
BMJ. Vol 319. Sept 1999: 670-674
http://bmj.com/cgi/content/full/319/7211/670?maxtoshow=?eaf
NOTE: Delfini agrees that
differential loss is important to note, but even equivalent loss of greater
than five percent could be a threat to validity.
More reading: Intention-to-Treat
Analysis — The Biased Case of Migraine at our Evidence
Essentials Page.
Click here to go to Delfini critical appraisal tools in our Evidence Tool
Set and here for Delfini White Paper on Missing Data.
Advanced Reading
Lachin JM.
Statistical considerations in the intent-to-treat principle.
Control Clin Trials 2000;21:167–189. PMID: 11018568 |
Placebo Effect |
Not reading exactly, but incredibly informative and entertaining:
The Strange Powers of the Placebo Effect
http://www.youtube.com/watch?v=yfRVCaA5o18 |
Assessing
Harms |
Effective
Health Care
Methods Guide for Comparative Effectiveness Reviews
Assessing
Harms When Comparing Medical Interventions
Citation: Chou R,
Aronson N, Atkins D, et al. Assessing harms when comparing medical interventions.
In: Agency for Healthcare Research and Quality. Methods Guide for Comparative
Effectiveness Reviews [posted November 2008]. Rockville, MD. |
Systematic
Reviews & Meta-analyses |
Strite
SA, Stuart ME.
An Introduction to Systematic Reviews: The Lifeblood of Medical
Decision-making.
California Pharmacist 2008. Vol LV, No. 3. Summer 2008: 52-56.
http://www.delfini.org/Showcase_Publication_Formulary.htm
Oxman AD, Cook DJ, Guyatt
GH. How to use an Overview.
User’s Guides to Evidence-based Medicine.
JAMA. 1994 Nov 2; 272 (17): 1367-71
Egger M, Smith GD, Phillips
AN
Meta-analysis: principles and procedures.
BMJ. 1997: 315:1533-1537.
(BMJ has a great site in their collections:
http://www.bmj.com/content/315/7121/1533?view=long&pmid=9432252)
Miser WF
Applying a Meta-Analysis to Daily Clinical Practice.
J Am Board Fam Pract 13(3) : 201-210, 2000.
This tool is currently unavailable online.
Delfini suggestions and commentary on the Miser article and evaluation tool: |
•
Under “Was the method for selecting articles…”
Question 3. Was selection done blindly and in random order –
means “Were the articles presented in random order to reviewers
and were reviewers blinded [communication from author]. All relevant
studies should be reviewed.
• Often
it is recommended that all studies selected should go in the same
direction of treatment effect. The issue is trying to ensure that
the studies were similar enough to combine — if the results
are very different, that may point to a dissimilarity in studies.
All relevant studies should be sought using selection criteria,
including those in grey literature to address potential for publication
bias of lack of reporting of negative finding studies. Doing systematic
reviews is complicated. Sensitivity analyses should be done and
reported, along with a robust discussion by the authors of potential
differences in studies. |
Also, we've included on our
site our own Delfini Systematic Review Validity Tool. Click here to go to Delfini critical appraisal tools in our Evidence Tool Set. |
Diagnostic
Testing |
Jaeschke
R et al.
How to Use an Article About a Diagnostic Test. Users’ Guides
to Evidence-based Medicine
JAMA.
http://www.jamaevidence.com/resource/520
Greenhalgh T.
How to read a paper: Papers that report diagnostic or screening tests.
BMJ 1997; 315:540-3
http://bmj.bmjjournals.com/cgi/content/full/315/7107/540
Fletcher,
Robert H, Suzanne W. Fletcher and Edward H. Wagner Clinical Epidemiology:
The Essentials. Philadelphia PA. Lippincott Williams & Wilkins, 1996.
Bandolier at http://www.bandolier.org.uk/
• Delfini Diagnostic Testing Calculator Online
[Excel]
Features:
• Natural language
explanations for results. Can use with patients.
• Provides
information in percents, probabilities and odds.
• Likelihood
ratio results computed for you so you don't have to guess what is “insignificant”
and what is “large.” The calculator does the interpretive
work for you.
• Bandolier
number-needed-to-diagnose (NND) calculated as well.
• Calculates on the basis of —
• pre-test likelihood, sensitivity and specificity
• raw data from a 2x2 table
• Links to confidence interval calculator
• Delfini Primer: "Evaluating Diagnostic Tests: Challenges
with Measures of Test Function" online at Evidence
Essentials
Download helpful one-pager that helps you better understand complexities
of diagnostic testing measures »
STARD for Standards in Reporting of Diagnostic Accuracy
Click here to go to the Delfini Diagnostic Testing
Tool Set. |
Equivalence
& Non-inferiority Trials |
-
Cleophas TJ, Zwinderman AH. Limitations of randomized clinical trials. Proposed alternative designs. Clin Chem Lab Med. 2000 Dec;38(12):1217-23. Review. PubMed PMID: 11205684.
-
Committee for Medicinal Products for Human Use; Efficacy Working Party; Committee for Release for Consultation. Committee for Medicinal Products for Human Use (CHMP) guideline on the choice of the non-inferiority margin. Stat Med. 2006 May 30;25(10):1628-38. PMID: 16639773
-
D'Agostino RB Sr, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics. Stat Med. 2003 Jan 30;22(2):169-86. PMID: 12520555
-
Gøtzsche PC. Lessons from and cautions about noninferiority and equivalence randomized trials. JAMA. 2006 Mar 8;295(10):1172-4. PubMed PMID: 16522840.
-
Jones B et al. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996; 313:36-39 (6 July)
-
Kirshner B. Methodological standards for assessing therapeutic equivalence. J Clin Epidemiol 1991. Vol. 44, No 8: 839-849
-
Lange S, Freitag G. Choice of delta: requirements and reality--results of a systematic review. Biom J. 2005 Feb;47(1):12-27; discussion 99-107. Review. PMID: 16395993
-
Le Henanff A, Giraudeau B, Baron G, Ravaud P. Quality of reporting of noninferiority and equivalence randomized trials. JAMA. 2006 Mar 8;295(10):1147-51. PubMed PMID: 16522835.
-
Piaggio G et al. Reporting of Noninferiority and Equivalence Randomized Trials: An Extension of the CONSORT Statement JAMA. 2006;295:1152-1160. PMID: 16522836.
-
Sanjay Kaul B et al. Good Enough: A Primer on the Analysis and Interpretation of Noninferiority Trials. Ann Intern Med. 2006;145:62-69. PMID 16522836
-
Snapinn S. Noninferiority trials [commentary]. Curr Control Trials Cardiovasc Med 2000;1:19-21
-
Wiens BL. Choosing an equivalence limit for noninferiority or equivalence studies. Control Clin Trials. 2002 Feb;23(1):2-14. Erratum in: Control Clin Trials 2002 Dec;23(6):774. PMID: 11852160
|
Statistics |
By John C. Pezzullo, PhD
Excepts From Our Review on Amazon
Great Help for Critical Appraisers
- An excellent resource
- Useful to critical appraisers because it can help us understand why certain common statistical tests are used in studies
- Provides a needed resource for answering questions about various tests
- Helpful explanations
- Written in a clear style with the goal of making difficult information accessible and understandable
- Friendly style due to author's wit and charm, and the reassurance he provides along the way
Read our full review here. Go to Amazon page and full customer reviews here. |
Cost-analysis
and Cost-effectiveness Analysis |
Gold
MR, Siegel JE, et al., Eds. (1996)
Cost-Effectiveness in Health and Medicine. New York,
Oxford University Press. |
Ganiats
TG
Cost-effective analysis.
Primary Care. 22(2): 307-318, 1995.
Deyo R
Cost-effectiveness of Primary Care.
J Am Board Fam Pract 13(1):47-54, 2000. PMID: 10682885
Ramsey S et al
Weighing the Economic Evidence: Guidelines for Critical Assessment
of Cost-Effectiveness Analyses.
J Am Board Fam Pract 12(6): 477-485, 1999.
PubMed PMID: 10612366
Click here to see our Examples of Cost Analysis Tools. |
Visual
Display of Information |
Everything
by Edward Tufte! www.edwardtufte.com.
Click here to go to our online
newsletter of examples of information and decision aids for practitioners
and patients — On the Same Page ™. |
General Online Articles About Medical Science |
The Blog of Scott K. Abergg, MD MPH: medicalevidence.blogspot.com
Why Almost Everything You Hear About Medicine is Wrong by Sharon Begley in Newsweek, January 24, 2011
The
Truth Wears Off: Is there something wrong with the scientific method? by Jonah Lehrer in The New Yorker, December 13, 2010
Related Article & Regression-to-the-Mean Explanation:
Study vs. Study: The Decline Effect and Why Scientific 'Truth' So Often Turns Out Wrong—It May Not Be So Surprising That Study Findings Don't Always Hold Up
by John Allen Paulos, ABC News/Technology, January 2, 2011
About the work of Professor John Ioannidis MD and the medical misinformation challenge:
Letter
to the Editor, How to Evaluate Medical Science and "Lies,
Damned Lies, and Medical Science" by David H. Freedman in
The Atlantic, November 2010. |
........
CONTACT DELFINI |
Return
to Top
© 2002-2020 Delfini Group, LLC. All Rights Reserved Worldwide.
Use of
this website implies your agreement to our Notices.
EBM Solutions
for Evidence-based Health Care Quality
|